COVID-19 vaccination: effective utilization of low dead space (LDS) syringes.

Shinozuka, Jun; Hata, Michiaki; Eguchi, Hiromi; Mori, Masahiro; Eguchi, Mitsunori; Fukui, Mototaka; Sai, Natsuki; Imashuku, Shinsaku; Sueyoshi, Atsushi

Shinozuka, Jun; Hata, Michiaki; Eguchi, Hiromi; Mori, Masahiro; Eguchi, Mitsunori; Fukui, Mototaka; Sai, Natsuki; Imashuku, Shinsaku; Sueyoshi, Atsushi.

Shinozuka J; Infection Control Committee.
Hata M; Division of Emergency and Critical Care Medicine.
Eguchi H; Infection Control Committee.
Mori M; Infection Control Committee; Department of Laboratory Medicine.
Eguchi M; Department of Laboratory Medicine.
Fukui M; Division of Respiratory Medicine.
Sai N; Division of Respiratory Medicine.
Imashuku S; Department of Laboratory Medicine. Electronic address: shinim95@mbox.kyoto-inet.or.jp.
Sueyoshi A; Director, Uji-Tokushukai Medical Center, Uji, Kyoto 611-0041, Japan.

Int J Infect Dis ; 113: 90-92, 2021 Dec.

Article in English | MEDLINE | ID: covidwho-1440099

Subject(s)

COVID-19; Syringes; COVID-19 Vaccines; Humans; SARS-CoV-2; Vaccination

Keywords

COVID-19; Pfizer vaccine; effective utilization; low dead space syringe

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Syringes / COVID-19 Type of study: Experimental Studies Topics: Vaccines Limits: Humans Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google